Bloom8
Overview
Bloom8 is a venture capital firm specializing in foodtech, climatetech and select pre-IPO opportunities . The firm seeks investments in early-stage and later-stage companies . Bloom8 prefers to make investments in the food-tech sector .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tropic Biosciences | Jul 2022 | Series C | - |
| Oishii | Nov 2024 | Series B Extension | Co-investor |
| Fazenda Futuro | Nov 2021 | Series C | Lead |
| Remilk | Jan 2022 | Series B | - |
| Ripple Foods | Sep 2021 | Series E | Lead |
For institutional investors. Book with your work email.
Key People
Gabriel Ruimy
Co-founder, Managing Partner
Brandon Chong
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bloom8 based?
Bloom8 is headquartered in New York City, New York, United States.
When was Bloom8 founded?
Bloom8 was founded in 2018.
How many portfolio companies does Bloom8 have?
Bloom8 has 11 portfolio companies in Caplight's dataset.
What are some companies in Bloom8's portfolio?
Portfolio companies visible on Caplight include Tropic Biosciences, Oishii, Fazenda Futuro, Remilk, Ripple Foods.
What was Bloom8's most recent investment shown here?
Bloom8's most recent investment in this portfolio sample was in Oishii in 2024.
What sectors does Bloom8 focus on?
Bloom8 focuses on Consumer & Commerce, Consumer & Commerce, Media, Entertainment & Gaming, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Energy & Sustainability, Consumer & Commerce, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Bloom8 focus on?
Bloom8 typically invests at the Mid stage.
What is Bloom8's AUM?
Bloom8's assets under management are estimated between $50.0M and $100.0M.